01

drip · atlas · cosmetic

follicle stimulation.

nudging hair follicles into and through the active growth phase of their cycle.

addresses · hair loss · scalp

02

biology

what it is

hair follicles cycle continuously between three phases: anagen (active growth), catagen (transition), and telogen (rest). the percentage of follicles in anagen at any time, and the duration of an individual anagen phase, set what consumers experience as hair density and length potential. as those shift toward shorter anagen and longer telogen, the visible result is thinning.

follicle-stimulating peptides target the dermal papilla, the cluster of cells at the base of each follicle that orchestrates the cycle. signaling from the papilla determines whether a follicle enters or stays in the active growth phase. peptides can supply or amplify those signals.

drip's discovery pipeline scores candidates on predicted dermal-papilla activation along with predicted irritation, stability in scalp formulations, and absorption through the scalp surface. the goal is a sequence that produces a visible density effect within the cosmetic envelope, not a drug-tier intervention.

03

reference

commodity peptides in this family

  • Acetyl Tetrapeptide-3 / Capixyl
  • Biotinyl-GHK / Procapil

editorial reference. drip discovery returns novel sequences, not these.

04

creators

brands targeting this

creators shipping a drip-discovered alternative against follicle stimulation appear here. each row carries the brand, its tier ( proof, verified, or clinical), the activity it targets, and a deep link to its storefront.

zero brands listed today. listings wire up when the brand-by-target index lands.

ship the first brand against follicle stimulation

05

literature

peer-reviewed pathway references

pathway reference list lands with the editorial review pass.

06

ship against this activity

start a brand. or pull this through the API.